Cyclophosphamide
Chemotherapeutic Toxicity
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolSmall moleculePhase 4 / ApprovedActive
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 53/ 100
- Competitive Position
- 81/ 100
Competitive context
13 Active assets in the Chemotherapeutic Toxicity cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
PREDNISONE TABLETS Instituto do Cancer do Estado de São Paulo | Phase 4 | BB |
Inno-206 Instituto do Cancer do Estado de São Paulo | Phase 4 | BB |
Clostridium Butyricum The Affiliated Hospital of Qingdao University | Phase 4 | B |
Daunorubicin Instituto do Cancer do Estado de São Paulo | Phase 4 | B |
Bortezomib Hospital General de Mexico | Phase 4 | B |
View all 21 →
Same molecule, other indications
Cyclophosphamide is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →